The National Animal Supplement Council (NASC) has announced a pioneering safety study exploring the use of CBD products for healthy dogs, recently showcased in Frontiers in Veterinary Science.

​

This groundbreaking study, the first of its kind, examined the effects of various cannabinoids on dogs over a 90-day duration, followed by a 14-day recovery phase. The results indicate that CBD products are well-tolerated by dogs at a dosage of 5mg/kg of body weight per day, with no notable risks observed during prolonged use.

​

Bill Bookout, President of NASC, emphasized the significance of these findings, stating, "These data demonstrate that different cannabinoids are safe for long-term use in healthy dogs." The study's comprehensive approach integrated a decade's worth of post-market surveillance data from the NASC Adverse Event Reporting Database (NAERS®), making it one of the most extensive studies of its kind.

​

For those interested in exploring the study further, the complete publication is available for review here: https://www.nasc.cc/news/national-animal-supplement-council-announces-publication-of-landmark-safety-study-of-cannabidiol-products-in-healthy-dogs

 

This significant milestone underscores NASC's dedication to promoting the health and well-being of companion animals while upholding industry integrity.

​

To learn more about NASC and its initiatives, please visit NASC's website: www.nasc.cc